---
title: Alloengraftment without significant toxicity or GVHD in CD45 antibody-drug
  conjugate conditioned Fanconi anemia mice
date: '2024-03-06'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38447038/?utm_source=curl&utm_medium=rss&utm_campaign=journals&utm_content=7603509&fc=None&ff=20240307170556&v=2.18.0.post9+e462414
source: Blood
description: Fanconi anemia (FA) is an inherited DNA repair disorder characterized
  by bone marrow (BM) failure, developmental abnormalities, myelodysplasia, and leukemia
  and solid tumor predisposition. Allogeneic hematopoietic stem cell transplantation
  (allo-HSCT), a mainstay treatment, is limited by conditioning regimen-related toxicity
  and graft-versus-host disease (GVHD). Antibody-drug-conjugates (ADCs) targeting
  hematopoietic stem cells (HSCs) can open marrow niches permitting donor stem ...
disable_comments: true
---
Fanconi anemia (FA) is an inherited DNA repair disorder characterized by bone marrow (BM) failure, developmental abnormalities, myelodysplasia, and leukemia and solid tumor predisposition. Allogeneic hematopoietic stem cell transplantation (allo-HSCT), a mainstay treatment, is limited by conditioning regimen-related toxicity and graft-versus-host disease (GVHD). Antibody-drug-conjugates (ADCs) targeting hematopoietic stem cells (HSCs) can open marrow niches permitting donor stem ...